Publications by authors named "Rose-Marie Rebillard"

Article Synopsis
  • Multiple sclerosis (MS) is an autoimmune disease that damages myelin in the central nervous system, leading to injury of brain and spinal cord cells due to immune cell infiltration, particularly by pro-inflammatory Th17 cells.
  • The study investigated how these Th17 cells interact with oligodendrocytes (the myelin-producing cells) through specific adhesion molecules, finding that the presence of certain molecules like ALCAM helps these cells adhere, which can lead to cell death.
  • Results showed that in the presence of inflammatory cytokines or activated T cells, the expression of MCAM decreased, offering protective insights that targeting ALCAM could reduce harmful interactions between Th17 cells and oligodendrocytes, potentially leading to new therapeutic strategies for
View Article and Find Full Text PDF
Article Synopsis
  • MOGAD is a newly identified neuroinflammatory disease characterized by the presence of anti-MOG antibodies, with symptoms varying widely among patients.
  • A study conducted in Quebec found a prevalence of 0.52 cases per 100,000 people, with optic neuritis and acute disseminated encephalomyelitis being the most common initial symptoms.
  • Only 38% of patients fully recovered within 4 weeks, and a significant number of patients experienced relapses and residual deficits, indicating a serious disease course for many.*
View Article and Find Full Text PDF

The migration of circulating leukocytes into the central nervous system (CNS) is a key driver of multiple sclerosis (MS) pathogenesis. The monoclonal antibody natalizumab proved that pharmaceutically obstructing this process is an effective therapeutic approach for treating relapsing-remitting MS (RRMS). Unfortunately, the clinical efficacy of natalizumab is somewhat offset by its incapacity to control the progressive forms of MS (PMS) and by life-threatening side effects in RRMS rising from the expression of its molecular target, very late antigen 4 (VLA4), on most immune cells and consequent impairment of CNS immunosurveillance.

View Article and Find Full Text PDF

Despite advances in COVID-19 management, identifying patients evolving toward death remains challenging. To identify early predictors of mortality within 60 days of symptom onset (DSO), we performed immunovirological assessments on plasma from 279 individuals. On samples collected at DSO11 in a discovery cohort, high severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA (vRNA), low receptor binding domain–specific immunoglobulin G and antibody-dependent cellular cytotoxicity, and elevated cytokines and tissue injury markers were strongly associated with mortality, including in patients on mechanical ventilation.

View Article and Find Full Text PDF

Dysregulated immune profiles have been described in symptomatic patients infected with SARS-CoV-2. Whether the reported immune alterations are specific to SARS-CoV-2 infection or also triggered by other acute illnesses remains unclear. We performed flow cytometry analysis on fresh peripheral blood from a consecutive cohort of (a) patients hospitalized with acute SARS-CoV-2 infection, (b) patients of comparable age and sex hospitalized for another acute disease (SARS-CoV-2 negative), and (c) healthy controls.

View Article and Find Full Text PDF

Objective: Adult drug-resistant epilepsy (DRE) is associated with significant morbidity. Infiltration of immune cells is observed in DRE epileptic foci; however, the relation between DRE and the peripheral immune cell compartment remains only partially understood. We aimed to investigate differences in immune cell populations, cytokines, and neurodegenerative biomarkers in the peripheral blood of subjects with epilepsy versus healthy controls, and in DRE compared to well-controlled epilepsy (WCE).

View Article and Find Full Text PDF

Objective: Polygenic risk scores (PRSs) are used to quantify the cumulative effects of a number of genetic variants, which may individually have a very small effect on susceptibility to a disease; we used PRSs to better understand the genetic contribution to common epilepsy and its subtypes.

Methods: We first replicated previous single associations using 373 unrelated patients. We then calculated PRSs in the same French Canadian patients with epilepsy divided into 7 epilepsy subtypes and population-based controls.

View Article and Find Full Text PDF
Article Synopsis
  • TCR1640 mice are engineered to develop a condition similar to multiple sclerosis, showing different disease courses based on sex; females mostly experience a relapsing-remitting (RR) form while males tend to have a progressive form.
  • Researchers conducted experiments transferring immune cells from both male and female TCR1640 mice into wild-type (WT) mice to see if the disease course is influenced by the donor's or recipient's sex.
  • The study found that the female donor cells caused RR disease while male donor cells resulted in a progressive course, indicating that sex differences in gene expression among immune cells play a role in the type of neuroinflammatory disease observed.
View Article and Find Full Text PDF
Article Synopsis
  • CD70 is a ligand for CD27 that is only expressed on activated immune cells, making its engagement crucial for immune responses.
  • The upregulation of CD70 on CD4 T lymphocytes, induced by TGF-β1 and TGF-β3, enhances their ability to migrate into the central nervous system and promotes a pathogenic phenotype.
  • CD70 is associated with T1 and T17 lymphocyte profiles, playing a significant role in T-bet and IFN-γ expression, and its presence in the CNS during autoimmune inflammation suggests it is a key immune marker and costimulator for pathogenic T lymphocytes.
View Article and Find Full Text PDF

Rasmussen's encephalitis (RE) is a chronic inflammatory brain disorder that causes frequent seizures and unilateral hemispheric atrophy with progressive neurological deficits. Hemispherectomy remains the only treatment that leads to seizure freedom for this refractory epileptic syndrome. The absence of an animal model of disease has been a major obstacle hampering the development of effective therapies.

View Article and Find Full Text PDF

During development, the risk of developing mesial temporal lobe epilepsy (MTLE) increases when the developing brain is exposed to more than one insult in early life. Early life insults include abnormalities of cortical development, hypoxic-ischemic injury and prolonged febrile seizures. To study epileptogenesis, we have developed a two-hit model of MTLE characterized by two early-life insults: a freeze lesion-induced cortical malformation at post-natal day 1 (P1), and a prolonged hyperthermic seizure (HS) at P10.

View Article and Find Full Text PDF

Clinical evidence suggests that febrile status epilepticus (SE) in children can lead to acute hippocampal injury and subsequent temporal lobe epilepsy. The contribution of febrile SE to the mechanisms underlying temporal lobe epilepsy are however poorly understood. A rat model of temporal lobe epilepsy following hyperthermic SE was previously established in our laboratory, wherein a focal cortical lesion induced at postnatal day 1 (P1), followed by a hyperthermic SE (more than 30 min) at P10, leads to hippocampal atrophy at P22 (dual pathology model) and spontaneous recurrent seizures (SRS) with mild visuospatial memory deficits in adult rats.

View Article and Find Full Text PDF

A PHP Error was encountered

Severity: Warning

Message: fopen(/var/lib/php/sessions/ci_sessionff0m0at0j6cg8jc4n9rk1eq40oujg0j2): Failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 177

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)

Filename: Session/Session.php

Line Number: 137

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once